Raymond James Trust N.A. boosted its holdings in Envision Healthcare Corporation (NYSE:EVHC) by 13.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,831 shares of the company’s stock after buying an additional 1,024 shares during the period. Raymond James Trust N.A.’s holdings in Envision Healthcare Corporation were worth $554,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in EVHC. Vanguard Group Inc. raised its holdings in Envision Healthcare Corporation by 4.0% in the first quarter. Vanguard Group Inc. now owns 11,266,818 shares of the company’s stock worth $690,881,000 after purchasing an additional 433,593 shares during the period. Wellington Management Group LLP raised its holdings in Envision Healthcare Corporation by 1.2% in the first quarter. Wellington Management Group LLP now owns 9,512,290 shares of the company’s stock worth $583,294,000 after purchasing an additional 108,389 shares during the period. BlackRock Inc. raised its holdings in Envision Healthcare Corporation by 3,895.0% in the first quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock worth $441,359,000 after purchasing an additional 7,017,467 shares during the period. State Street Corp raised its holdings in Envision Healthcare Corporation by 4.1% in the first quarter. State Street Corp now owns 4,862,721 shares of the company’s stock worth $298,178,000 after purchasing an additional 193,547 shares during the period. Finally, Janus Capital Management LLC raised its holdings in Envision Healthcare Corporation by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock worth $167,536,000 after purchasing an additional 1,055,014 shares during the period. Institutional investors and hedge funds own 64.75% of the company’s stock.

In related news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $62.69, for a total transaction of $94,035.00. Following the transaction, the insider now owns 97,863 shares in the company, valued at approximately $6,135,031.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.10% of the stock is owned by insiders.

Several research firms have weighed in on EVHC. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Mizuho cut their target price on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating on the stock in a report on Wednesday, August 9th. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 target price on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. BidaskClub lowered shares of Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $72.00 target price on shares of Envision Healthcare Corporation in a report on Monday, June 5th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Envision Healthcare Corporation presently has a consensus rating of “Buy” and an average price target of $71.56.

Shares of Envision Healthcare Corporation (NYSE EVHC) opened at 48.49 on Friday. Envision Healthcare Corporation has a one year low of $47.47 and a one year high of $74.75. The company’s 50 day moving average is $51.97 and its 200-day moving average is $57.86. The firm’s market capitalization is $5.68 billion.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.96 billion. During the same quarter in the previous year, the company earned $0.34 EPS. Envision Healthcare Corporation’s quarterly revenue was up 156.7% compared to the same quarter last year. Equities analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Raymond James Trust N.A. Has $554,000 Position in Envision Healthcare Corporation (EVHC)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/16/raymond-james-trust-n-a-has-554000-position-in-envision-healthcare-corporation-evhc.html.

Envision Healthcare Corporation Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.